This week, the results from a clinical trial of 250 participants with progressive MS were released and showed that ibudilast on had a significant impact in slowing down brain volume…
Read More
This past month, the MSYPN met with RMMSC Board Chair, Del Arnold, and Board Member, Erica Tarpey. Del and Erica discussed their careers, what led them to the RMMSC board, and…
Medical appointments tend to be too short to address all our concerns and care does not always feel patient-centered. In an effort to reme-dy these common experiences and give patients…
An Interview with Dr. Roger Enoka with the Neurophysiology of Movement Laboratory at University of Colorado Boulder campus Dr. Roger Enoka, a professor at the University of Colorado Boulder, has…
Quite a bit’s going on in the world of disease modifying therapies (DMTs), and we’ve prepared a brief update for you. Read on for more about Gilenya’s FDA approval for…
The Rocky Mountain MS Center hosted the 2018 Spring Education Summit in Aurora on Saturday, May 12. We’ve archived the main content of the Summit to share with everyone that…
Join RMMSC Medical Director Dr. Timothy Vollmer for an in-depth look at disease modifying therapies (DMTs) – the front line in our fight against MS. This webinar will give you…
In 2018, the Rocky Mountain MS Center is excited to celebrate our 40th Anniversary. Throughout the year, we will be sharing with you some of the significant events, developments and milestones…
The 2018 Multiple Summits for Multiple Sclerosis (MS4MS) campaign is underway! Join the Rocky Mountain MS Center in our efforts to conquer MS in this unique and fun event. MS4MS…
The Spring 2018 issue of InforMS magazine focuses on leisure: an often misunderstood and under-appreciated component of health and wellbeing. In this issue of eMS News, we’d like to tell…
